BURLINGTON, Mass., Jan. 6, 2024 /PRNewswire-PRWeb/ --Sacrix, a pioneer medical device company in outpatient spine surgery solutions, proudly unveils a novel Less Exposure Spine Surgery (LESS) technique that helped patients avoid major and risky revision corrective spine surgery. The clinical results were summarized in a research paper authored by Board-certified Orthopedic … [Read more...] about Sacrix Provides Safe Alternative to Risky Revision Spine Surgery, Publishing Groundbreaking Results in Renowned Spine Journal
NEWS
Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that effective immediately, Massimo Calafiore has assumed the role of President and Chief Executive Officer (CEO) and as a member of the Orthofix Board of Directors. In conjunction with Mr. Calafiore stepping into his role as CEO, the Company … [Read more...] about Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer
We are proud to announce that Centinel Spine will be Sponsor of SPINEMarketGroup again in 2024!
Thank you Centinel Spine! On behalf of the SPINEMarketGroup team, we would like to thank you for supporting our site again in 2024 through your PLATINUM sponsorship! About Centinel Spine, LLC Centinel Spine®, LLC is the leading global medical device company addressing cervical and lumbar spinal disease with the most clinically-proven total disc replacement (TDR) … [Read more...] about We are proud to announce that Centinel Spine will be Sponsor of SPINEMarketGroup again in 2024!
Eminent Spine’s 3D Titanium Anterior Lumbar Stand-Alone System Usage Report and Clinical Study
Plano, TX, January 04, 2024 --(PR.com)-- Eminent Spine received 510(k) approval of their 3D Titanium Anterior Lumbar Interbody Fusion Stand-Alone System in October of 2022. Since then, Eminent Spine has had a total of 40 3D Titanium ALIF Stand-Alone implants used in procedures in patients who were candidates for an Anterior Lumbar Interbody Fusion. The implants also … [Read more...] about Eminent Spine’s 3D Titanium Anterior Lumbar Stand-Alone System Usage Report and Clinical Study
We are proud to announce that Rudischhauser Surgical Instruments and Implants Manufacturing will be Sponsor of SPINEMarketGroup again in 2024!
Thank you Rudischhauser Surgical Instruments and Implants Manufacturing! On behalf of the SPINEMarketGroup team, we would like to thank you for supporting our site again in 2024 through your PLATINUM sponsorship. About Rudischhauser Surgical Instruments and Implants Manufacturing Your partner and OE-Manufacturer of superior instruments, implants and complete set … [Read more...] about We are proud to announce that Rudischhauser Surgical Instruments and Implants Manufacturing will be Sponsor of SPINEMarketGroup again in 2024!
Exciting FDA-Approved Products in the Pipeline for 2024: A Glimpse into the Dynamic Landscape of American Companies
With numerous FDA approvals, 2023 has proven to be a landmark year that paves the way for groundbreaking products. As we move into 2024, the spotlight is on American companies, particularly trailblazers like Eminent Spine and Astura Medical, which have been spearheading the approval process and already have captivating portfolios. Eminent Spine, a leading figure in the … [Read more...] about Exciting FDA-Approved Products in the Pipeline for 2024: A Glimpse into the Dynamic Landscape of American Companies
LEM Surgical AG Secures CHF 22 Million in Series B Funding to Ready Robotic System for FDA Submission
BERN, Switzerland, January 4, 2024 (Newswire.com) - LEM Surgical AG, an innovative surgical robotics company headquartered in Bern, Switzerland, announces the successful completion of its Series B funding, securing CHF 22 million. The round, which was strongly oversubscribed, reflects the strong investors’ confidence in LEM Surgical’s differentiated approach. This … [Read more...] about LEM Surgical AG Secures CHF 22 Million in Series B Funding to Ready Robotic System for FDA Submission
We are proud to announce that Genesys Spine will be Sponsor of SPINEMarketGroup again in 2024!
Thank you Genesys Spine! On behalf of the SPINEMarketGroup team, we would like to thank you for supporting our site again in 2024 through your PLATINUM sponsorship. About Genesys Spine Founded in December of 2009, Genesys Spine’s mission was to bring a suite of medical implants and instruments with novel characteristics into a mature spinal fusion market. Since that time, … [Read more...] about We are proud to announce that Genesys Spine will be Sponsor of SPINEMarketGroup again in 2024!
Cerapedics Files Final Module of the PMA Application for FDA Approval of a new P-15 Peptide Enhanced Bone Graft for Lumbar Spine Fusion
WESTMINSTER, Colo., Jan. 4, 2024 /PRNewswire/ -- Cerapedics Inc., a commercial-stage orthopedics company dedicated to redefining the standard of care for bone repair, today announced that it has filed the final module in the Pre-Market Approval (PMA) application with the U.S. Food and Drug Administration (FDA) for its investigational P-15 Peptide Enhanced Bone Graft. … [Read more...] about Cerapedics Files Final Module of the PMA Application for FDA Approval of a new P-15 Peptide Enhanced Bone Graft for Lumbar Spine Fusion
Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2
KEELE, England, Jan. 4, 2024 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for regenerating bone and managing infection in bone and soft tissue, is pleased to announce that its investee company, Renovos Biologics (Renovos), has been granted Breakthrough Device … [Read more...] about Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2
We are proud to announce that W+S Solutions will be Sponsor of SPINEMarketGroup again in 2024!
Thank you W+S Solutions! On behalf of the SPINEMarketGroup team, we would like to thank you for supporting our site again in 2024 through your PLATINUM sponsorship. About W+S Solutions GmbH The company W+S Solutions is a family-owned business founded in 2006 in Tuttlingen, Germany. We are specialized in the manufacturing of silicone handles for surgical instruments as … [Read more...] about We are proud to announce that W+S Solutions will be Sponsor of SPINEMarketGroup again in 2024!
We are proud to announce that Intech will be Sponsor of SPINEMarketGroup again in 2024!
Thank you Intech! On behalf of the SPINEMarketGroup team, we would like to thank you for supporting our site again in 2024 through your PLATINUM sponsorship. About Intech Intech is proud and happy to lead the way in the manufacturing of orthopedic instruments and implants that better patients’ lives.Powered by 1,000 Intechers across the globe, the company is a premiere … [Read more...] about We are proud to announce that Intech will be Sponsor of SPINEMarketGroup again in 2024!
Revolutionizing Spine Surgery: The Rise of Awake Spine Surgery
The field of spine surgery is continuously evolving, with advancements in tools such as robotics, imaging, and artificial intelligence contributing to safer and faster procedures. We've also discussed emerging approaches, materials, and implants. However, in the ever-evolving field of spine surgery, advancements continue to redefine traditional practices, and one such … [Read more...] about Revolutionizing Spine Surgery: The Rise of Awake Spine Surgery
CGBio’s ‘NOVOSIS PUTTY’ Receives FDA ‘Breakthrough Device Designation,’ Accelerate Entry into the US Market
SEOUL, South Korea, Jan. 2, 2024 /PRNewswire/ -- CGBio (CEO Hyun Seung Yu), a Korean company specializing in bio-regenerative medicine, announced on the 2nd that its advanced bone substitute material, "NOVOSIS PUTTY", has been granted 'Breakthrough Device Designation' (BDD) by the U.S. Food and Drug Administration (FDA). This material incorporates recombinant … [Read more...] about CGBio’s ‘NOVOSIS PUTTY’ Receives FDA ‘Breakthrough Device Designation,’ Accelerate Entry into the US Market
Welcoming 2024 with Gratitude and Commitment to the Spine Industry Community!
As we welcome the new year, we want to send warm wishes to all our friends—readers and sponsors alike. We appreciate your support, and we thank you for the trust you've given us. It has been the cornerstone of SPINEMarketGroup's success, and we are immensely grateful for the trust placed in us. Throughout the years, your engagement and feedback have been instrumental in … [Read more...] about Welcoming 2024 with Gratitude and Commitment to the Spine Industry Community!
Which Spine products have been launched in 2023?
In the year 2023, the landscape of spine product launches has undergone a noticeable shift. Unlike previous years marked by a flurry of introductions, this year has seen a more restrained approach, with a predominant focus on aligning company portfolios with prevailing product trends such as 3D technology, expansive cages, and sacral iliac implants. Notably absent from the … [Read more...] about Which Spine products have been launched in 2023?
What have been the Acquisitions in 2023?
In the spine market, there have been EIGHT acquisitions in 2023. Today, we share with you those that have occurred in this year until now. The spine industry has been undergoing a consolidation for some years. This situation may occur for several reasons: What have been the acquisitions in 2023? 9.- December: ZimVie Sells Spine Business to H.I.G. Capital What was … [Read more...] about What have been the Acquisitions in 2023?
Why Investment Firms Are Eyeing Spinal Implant Companies?
Yesterday, Zimvie announced its acquisition by the investment fund H.I.G. Capital. In the dynamic landscape of investment, a curious trend is emerging as investment funds increasingly set their sights on acquiring spinal implant companies. The intersection of healthcare innovation and financial strategy seems to be a compelling space for growth and profitability. Here are key … [Read more...] about Why Investment Firms Are Eyeing Spinal Implant Companies?
+3 Spanish Spine Companies to Know…!
The Spanish spinal implant market was valued in 2022 at €100 million with a growth rate of 3% annually. Economic factors, healthcare budget constraints, and reimbursement policies influence this market dynamics. These factors may pose challenges or opportunities for companies operating in the spine sector. The spinal fusion market in Spain can expand or contract due to … [Read more...] about +3 Spanish Spine Companies to Know…!